The importance of ROR1 has also been characterized in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, melanoma, ovarian cancer, and breast cancer [24, 36, 53, 75, 76]. Here, ROR1 is linked to breast carcinoma.